Biotechnology is often hailed as the future of cosmetic formulations. Here,, Director and Cosmetic Chemist at the Institute ...

Sam Altman, best known as the CEO of OpenAI, has steadily built a large and diverse investment portfolio that spans ...

Celebrating the top Seed stage investors in 2025 who made early bets on the startups driving today’s AI revolution.

It's been a challenging year for NovoCure (NASDAQ: NVCR), an oncology-focused biotech. NovoCure's average price target on ...

Vir Biotechnology, Inc. , today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer, will participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare ...

Orchestra BioMed holds two best-in-class medical device therapies targeting large markets. Find out why OBIO stock is a Buy.

We assign Veeva’s commercial solutions a wide moat based on customer switching costs. Veeva CRM is Veeva’s cloud-based customer relationship management platform. It markets to pharmaceutical and ...

A federal judge in Vermont has granted a Russian-born scientist and Harvard University researcher release from immigration ...

SEOUL, May 15 (UPI) -- The United States extended its ban on travel to North Korea for the ninth year in a row, a federal ...

Flexible Vision Inc today announced that Companies worldwide are on the cusp of realizing unprecedented financial benefits as Artificial Intelligence (AI) revolutionizes quality inspection processes.

Rocket Pharmaceuticals, Inc.’s (NASDAQ:RCKT) prospects have taken a significant hit on the company being forced to halt ...

Morrisville Councilman Steve Rao makes the case for the Triangle as a Silicon Valley of the East, and urges investors to explore this burgeoning market and its potential to redefine American ...